Alphabet leadership and others defend Verily's ambitious projects, Stat News reports.
Verily's life science projects aren't living up to expectations, Stat News reports.
The San Francisco Business Times examines Verily's latest hires.
Stat News examines ethical questions raised by Alphabet's Verily awarding a research contract to a clinic mostly owned by its CEO.
The Genome Analysis Toolkit is available on the Google cloud and will be launched on Amazon, Microsoft, and IBM's clouds and BaseSpace later this year.
Stat News looks into people departing Alphabet's life sciences company, Verily.
Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.
Alphabet is the world's most valuable company now, and its Verily healthcare subsidiary is close to being self-supporting.
Google's Life Science Division has the new, though old fashioned-sounding, name of Verily, Stat News reports.
Developers of proposals selected for the NCI-funded Cancer Genomics Cloud pilots have kicked of various stages of platform testing ahead of the nine-month evaluation phase
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.